| 名稱 | CDK12 p.Q1088* Reference Standard 標(biāo)準(zhǔn)品 |
| 型號(hào) | CBP10541 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | CDK12 p.Q1088* Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- *針對(duì)肝癌的PD-1抗體獲FDA批準(zhǔn)，國產(chǎn)PD-1抗體進(jìn)入三期
- 細(xì)胞株購買為何比較看重生物等級(jí)？
- 【靶點(diǎn)模型】AKT基因的藥物開發(fā)
- NKG2A細(xì)胞篩選模型
- 【論文作者回應(yīng)】小蘇打“餓死”腫瘤？教授為你答疑解惑
- TSHR細(xì)胞模型簡介
- KIR3DL3/HHLA2細(xì)胞篩選模型
- 重磅！科學(xué)家成功利用免疫細(xì)胞運(yùn)輸抗癌藥物至腫瘤靶點(diǎn)
- PNAS：腫瘤細(xì)胞或可“拆用”間充質(zhì)干細(xì)胞來促進(jìn)乳腺癌復(fù)發(fā)
- 雙面PD1，Blocker已成卷王，agonist賽道你上車了嗎？
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > Mutation > CBP10541CDK12 p.Q1088* Reference Standard 標(biāo)準(zhǔn)品
- 詳細(xì)內(nèi)容
| CBP10541 | |
| Format | Genomic DNA |
| Description | CDK12, cyclin dependent kinase 12, is a key regulator of transcription elongation, regulates the expression of genes involved in DNA repair, and is required for the maintenance of genomic stability (PMID: 24554720; PMID: 22012619). Loss and/or inactivation of CDK12 has been commonly observed in many solid tumor types, including prostate (PMID: 29906450, PMID: 31640893), breast, ovarian, endometrial, uterine (PMID: 30104286), and is a likely tumor suppressor (PMID: 30319007). |
| Technical Data | |
| DNA Change: | c.3262C>T |
| AA Change | p.Q1088* |
| Mutation type | Nonsense_Mutation |
| Zygosity | Heterozygous |
| Allelic Frequency | 33.33% |
| Transcript | NM_016507.4 |
| Cosmic ID | COSM472690 |
| Chr position(GRCh37) | chr17:37681093 |
| Buffer: | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)